Try it
ENT · Head and neck tumours: IMRT parotid sparing
Sample itemA patient with nasopharyngeal carcinoma is treated with a technique that shapes the dose to spare the parotid glands. What is the main benefit?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Reduced xerostomia
Intensity-modulated radiotherapy shapes high doses to the target and spares organs at risk, such as the parotids, so that radiation-induced xerostomia is reduced. It has become standard for head and neck cancers. Other toxicities still occur.
Option by option
A. Reduced xerostomia (correct)
Correct. Saliva flow is better preserved.
B. Reduced risk of hypothyroidism to zero
Hypothyroidism can still occur.
C. Reduced hearing loss to zero
Hearing loss can still occur.
D. Higher tumour dose with no side effects
Side effects remain.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More ENT questions
- AudiologyIn a tuning fork test, Rinne is negative (bone conduction louder than air conduction) in…
- EarWhich type of chronic suppurative otitis media is considered 'unsafe'?
- LarynxIn singers, vocal nodules typically occur at:
- Vestibular disordersA patient has recurrent attacks of vertigo lasting hours, with fluctuating low-frequency…